{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:21:04Z","timestamp":1780586464183,"version":"3.54.1"},"reference-count":19,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T00:00:00Z","timestamp":1247529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> The effect of plasmapheresis on cytokine levels in patients with myasthenia gravis (MG) has not been well established.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Cytokine levels were measured in 19 patients with MG before and after treatment with one course of double\u2010filtration plasmapheresis (DFP). The control group comprised 6 age\u2010 and sex\u2010matched healthy volunteers.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> At baseline, patients with MG had higher levels of IL\u201010 than normal controls. The levels of IL\u20102, IL\u20104, IL\u20105, and tumor necrosis factor\u2010\u03b1 were almost undetectable in MG patients. After a single session of DFP treatment, IL\u201010 levels were significantly increased. After three sessions, IL\u201010 levels were still higher than those at baseline. Elevated IL\u201010 level was significantly associated with use of immunosuppressant drugs, thymectomy, and good response to DFP treatment.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Interleukin\u201010 might play a crucial role in the pathogenesis and perpetuation of MG.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2009.02729.x","type":"journal-article","created":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T10:58:46Z","timestamp":1247569126000},"page":"1318-1322","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis"],"prefix":"10.1111","volume":"16","author":[{"given":"J.\u2010H.","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.\u2010H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.\u2010J.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.\u2010M.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.\u2010C.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,11,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70063-8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867033456918"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300110"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.8.933"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.2.287"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(93)90055-4"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000014434"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00129-4"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90044-2"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90080-9"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.01062.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199705)20:5<543::AID-MUS2>3.0.CO;2-9"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000069079"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20061"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1309\/L0DG8YU2WE5DV58H"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000170250"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2001.00386.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(96)00152-X"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2002.00466.x"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2009.02729.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2009.02729.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T14:57:02Z","timestamp":1696949822000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2009.02729.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,17]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1111\/j.1468-1331.2009.02729.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02729.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,17]]},"assertion":[{"value":"2009-11-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}